法人別リリース

Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists

Jolly Good — Thu, 01 Apr 2021 17:00:00 +0900

TOKYO, April 1, 2021 /Kyodo JBN/ --
Jolly Good Inc.
Leading Japanese medical VR company Jolly Good Inc. has recently established a specialized DTx Division to develop digital therapeutics (hereinafter “DTx”) using VR and AI technologies.

Logo: https://kyodonewsprwire.jp/img/202103313079-O1-CAsOT26u

Photo1: https://kyodonewsprwire.jp/img/202103313079-O2-2E7b1yar

Dr. Ayako Kanie and Dr. Aiichiro Nakajima, psychiatrists and leaders in the development of cognitive behavioral therapy at top research institutes in Japan, will officially participate in Jolly Good. The company has been developing social skill-training VR for developmental disabilities and digital therapeutics VR for depression. After agreeing that Jolly Good’s high-quality VR could be effective for mental illnesses, both doctors made the decision to participate.

Issues with Psychotherapy:

In many cases, drug therapy alone is insufficient to treat mental illnesses such as depression, and the importance of psychotherapy is gathering more attention. However, the issue with conventional psychotherapy is that it is not properly delivered to patients who need it, due to the lack of time and capability of specialists.

Jolly Good’s DTx Division has also applied for an international technology patent for providing personalized digital therapeutics by analyzing behavioral characteristics and vital data during the VR experience. Jolly Good is planning business expansion of digital therapeutics globally. Negotiations have started with several medical companies about global sales partnerships to this end.

Blockbuster TOKYO Business Pitch: A pharmaceutical & medical startup acceleration program sponsored by the Tokyo Metropolitan Government
https://youtu.be/TfvuMd9hKwc

Photo2: https://kyodonewsprwire.jp/img/202103313079-O3-EFN5NZ6I

Principal Members:

Photo3: Dr. Ayako Kanie
https://kyodonewsprwire.jp/img/202103313079-O4-gyK5I63p

Senior Medical Supervisor: Ayako Kanie, MD PhD
“The implementation of digital therapeutics using VR will increase treatment options for all kinds of people. By engaging with this development from its early stages, I hope to expand the potential of VR therapy and prevention.”

Specialty: Obsessive-compulsive disorder, anxiety disorder, depression, and schizophrenia

Photo4: Dr. Aiichiro Nakajima
https://kyodonewsprwire.jp/img/202103313079-O5-HS0e908z

Medical Supervisor: Aiichiro Nakajima, MD
"Digital therapeutics with VR enables delivery of high-quality treatment in short timeframes, delivering treatment to numerous patients in need. I expect that it will greatly contribute to the health of patients."

Specialty: Obsessive-compulsive disorder, anxiety disorder, depression, and schizophrenia

VR DTx official website https://vrdtx.com/en/

About Jolly Good Inc. (https://jollygood.co.jp/)
Jolly Good is a medical technology company that develops high-precision VR solutions and AI-based medical and welfare services that analyze user behavior in the VR space. Using technologies such as VR and AI, the company is accelerating human growth and social rehabilitation in medical education, support for persons with disabilities, treatment of mental illness, and so on, as well as developing services to support the evolution of medical care and finding purposes in life, in collaboration with various research institutions and companies.

Jolly Good and National Center for Cognitive Behavior Therapy and Research Enter Clinical Trial ....

Jolly Good — Thu, 02 Apr 2020 17:00:00 +0900

TOKYO, Apr. 2, 2020 /Kyodo JBN/ --
Jolly Good Inc.
Jolly Good and National Center for Cognitive Behavior Therapy and Research Enter Clinical Trial Collaboration for VR Therapeutics
-Partnership Aims to Develop World's First Cognitive Behavioral Therapy VR for Patients with Depression-

Jolly Good Inc. (hereinafter "Jolly Good") and the National Center for Cognitive Behavior Therapy and Research (hereinafter "NCCBTR") announced that they have entered into a clinical trial collaboration agreement directed toward the development of digital health solutions. Under the agreement, Jolly Good will develop and commercialize CBT VR in Japan and certain other overseas markets for patients with depression. Before the collaboration accord, Jolly Good applied for its "VR Diagnostic treatment system" patent in Japan on February 26, 2020 (patent application numbers: 2020-030723).

In the trial, the two partners will provide CBT focusing on positive-valence system using VR toward patients with moderate to higher depression. In addition, they will test the safeness and effectiveness of the VR therapeutics. The hypothesis is that by exposing patients under virtual reality related to positive-valence, it will decrease the suppression of activity making the patient available to find positive-valence in real-life situations as well. This will improve the symptoms of depressions, especially anhedonia. This research will prevent severe depression and decrease the number of hospitalized patients. In other words, the partners want to promote the use of VR and AI technology for effective treatment of depression that does not rely on drugs.

About Depression
Depressive disorders led to a global total of over 50 million Years Lived with Disability (YLD) in 2015. Globally, depressive disorders are ranked as the single largest contributor to non-fatal health loss (WHO, 2017).
Mental disorder is considered as one of the five major diseases in Japan. Among them, especially depression has a large percentage (1.27 million patients), and the annual economic cost of depression totals up to 3.09 trillion yen.

About Cognitive Behavioral Therapy (CBT)
The purpose of CBT is to relieve symptoms and prevent recurrence of depression in mood, physical responses, etc., caused by stress through strengthening patient self-control by applying theories and behavior modification techniques of cognitive behavioral science.

About Jolly Good
Jolly Good is a Japanese technology startup company that develops VR solutions and AI engines that analyze user behavior in VR space. The company designs advanced technologies and provides user-friendly solutions to many companies and local governments utilizing VR and AI in their businesses.
For more information visit: https://jollygood.co.jp/

About National Center for Cognitive Behavior Therapy and Research
The Center for Cognitive Behavior Therapy and Research is Japan’s first training and research center specializing in cognitive behavioral therapy (CBT). The center conducts its activities at The National Center of Neurology and Psychiatry ’s headquarters and a satellite office in Tokyo. The center implements the nation’s leading-edge research and training related to cognitive behavioral therapy.

For more information, visit: https://www.ncnp.go.jp/cbt/english/

Source: Jolly Good Inc.